Evidence map›Paper›PMID 37168517›Full record

ArticleIJID regions2023

First introduction of dengue virus type 3 in Niger, 2022.

Adamou Lagare, Martin Faye, Gbaguidi Fintan, Gamou Fall, Hadiza Ousmane, Elh Tassiou Ibrahim, Moussa Moise Diagne, Soumana Amadou, Safietou Sankhe, Laminou Ibrahim and 3 more

Abstract readCase Reports
In one paragraph

Article in IJID regions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Adamou LagareCentre de Recherche Médicale et Sanitaire (CERMES), 634 Bd de la Nation, Niamey, YN034, Niger.
Martin FayeVirology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur Dakar, 220, Dakar, Senegal.
Gbaguidi FintanClinique Gamkalle, Corniche Gamkalle, BP 324, Niamey, Niger.
Gamou FallVirology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur Dakar, 220, Dakar, Senegal.
Hadiza OusmaneCentre de Recherche Médicale et Sanitaire (CERMES), 634 Bd de la Nation, Niamey, YN034, Niger.
Elh Tassiou IbrahimMinistère de la Santé Publique, BP 623, Niamey, Niger.
Moussa Moise DiagneVirology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur Dakar, 220, Dakar, Senegal.
Soumana AmadouCentre de Recherche Médicale et Sanitaire (CERMES), 634 Bd de la Nation, Niamey, YN034, Niger.
Safietou SankheVirology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur Dakar, 220, Dakar, Senegal.
Laminou IbrahimCentre de Recherche Médicale et Sanitaire (CERMES), 634 Bd de la Nation, Niamey, YN034, Niger.
Haoua SeiniCentre de Recherche Médicale et Sanitaire (CERMES), 634 Bd de la Nation, Niamey, YN034, Niger.
Ousmane FayeVirology Department, Institut Pasteur de Dakar, 36 Avenue Pasteur Dakar, 220, Dakar, Senegal.
Ronan JambouCentre de Recherche Médicale et Sanitaire (CERMES), 634 Bd de la Nation, Niamey, YN034, Niger.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue fever is the most important mosquito-borne viral disease of humans, with a significant disease burden in tropical and subtropical countries. The disease is caused by four distinct dengue virus (DENV) serotypes, DENV-1 to -4, all of which belong to the family Flaviviridae, genus

Indexed as

dengue virusNiger

Identifiers

PMID37168517
PMCPMC10165393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.